HCV-话题@MedSci

#HCV#

247篇内容 | 3850人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1257643, encodeId=bbe6125e6434f, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Aliment Pharmacol The：真实世界数据告诉你OBV/PTV/r± DSV±RBV治疗HCV的疗效, objectType=article, longId=77177, objectId=063fe71772b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=063fe71772b, replyNumber=0, likeNumber=59, createdTime=2016-09-12, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=063fe71772b, moduleTitle=Aliment Pharmacol The：真实世界数据告诉你OBV/PTV/r± DSV±RBV治疗HCV的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=063fe71772b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257642, encodeId=7e41125e64239, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=丙肝病毒（HCV）研究进展, objectType=article, longId=76416, objectId=5028e6416a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5028e6416a3, replyNumber=0, likeNumber=20, createdTime=2016-09-02, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5028e6416a3, moduleTitle=丙肝病毒（HCV）研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5028e6416a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257641, encodeId=d5e6125e64177, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=治愈HCV感染，我们需要付出多大代价？, objectType=article, longId=76084, objectId=db5be608458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db5be608458, replyNumber=0, likeNumber=63, createdTime=2016-08-30, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db5be608458, moduleTitle=治愈HCV感染，我们需要付出多大代价？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db5be608458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257640, encodeId=1c7d125e6407d, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=2015INHSU建议——注射吸毒者HCV感染的管理发布, objectType=article, longId=75200, objectId=8e2ee5200ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e2ee5200ee, replyNumber=0, likeNumber=20, createdTime=2016-08-17, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e2ee5200ee, moduleTitle=2015INHSU建议——注射吸毒者HCV感染的管理发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e2ee5200ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257639, encodeId=212f125e639dc, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=AIM：接受阿片类药物激动剂治疗的HCV患者使用elbasvir-grazoprevir治疗的SVR12较高, objectType=article, longId=74873, objectId=3233e487368, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3233e487368, replyNumber=0, likeNumber=54, createdTime=2016-08-11, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3233e487368, moduleTitle=AIM：接受阿片类药物激动剂治疗的HCV患者使用elbasvir-grazoprevir治疗的SVR12较高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3233e487368)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257638, encodeId=042a125e6385c, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：直接抗病毒治疗HCV相关混合冷球蛋白血症是有效和安全的, objectType=article, longId=74597, objectId=38ebe459755, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38ebe459755, replyNumber=0, likeNumber=94, createdTime=2016-08-08, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38ebe459755, moduleTitle=Hepatology：直接抗病毒治疗HCV相关混合冷球蛋白血症是有效和安全的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=38ebe459755)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257637, encodeId=5155125e6378b, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Aliment Pharmacol Ther：ARFI成像预测持续HCV病毒应答患者的肝纤维化情况, objectType=article, longId=74498, objectId=e663e449884, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e663e449884, replyNumber=0, likeNumber=59, createdTime=2016-08-06, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e663e449884, moduleTitle=Aliment Pharmacol Ther：ARFI成像预测持续HCV病毒应答患者的肝纤维化情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e663e449884)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257636, encodeId=690c125e63662, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=AIDS 2016：感染HCV不会增加HIV病毒载量, objectType=article, longId=73574, objectId=3c19e357481, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c19e357481, replyNumber=0, likeNumber=81, createdTime=2016-07-25, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c19e357481, moduleTitle=AIDS 2016：感染HCV不会增加HIV病毒载量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c19e357481)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257635, encodeId=61aa125e6351a, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=“神药”OSU-03012不仅抑制多种肿瘤，也能抑制众多细菌和HIV、HAV、HBV、HCV等众多病毒, objectType=article, longId=73286, objectId=212ae328610, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=212ae328610, replyNumber=0, likeNumber=122, createdTime=2016-07-22, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=212ae328610, moduleTitle=“神药”OSU-03012不仅抑制多种肿瘤，也能抑制众多细菌和HIV、HAV、HBV、HCV等众多病毒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=212ae328610)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257634, encodeId=5ab4125e634d3, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Natl Cancer Inst：HCV感染可增加头颈癌的发生风险, objectType=article, longId=72166, objectId=5b49e21666a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b49e21666a, replyNumber=0, likeNumber=69, createdTime=2016-07-07, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b49e21666a, moduleTitle=J Natl Cancer Inst：HCV感染可增加头颈癌的发生风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b49e21666a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257633, encodeId=c2a0125e63308, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：新方法允许一步法诊断HCV感染, objectType=article, longId=70364, objectId=2b34e03641c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b34e03641c, replyNumber=0, likeNumber=87, createdTime=2016-06-11, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b34e03641c, moduleTitle=Hepatology：新方法允许一步法诊断HCV感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b34e03641c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257632, encodeId=2214125e632a5, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=J Viral Hepat：纳尼？！HCV治疗失败也会增加肝癌风险？, objectType=article, longId=68507, objectId=450c6850e5c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=450c6850e5c, replyNumber=0, likeNumber=67, createdTime=2016-05-19, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=450c6850e5c, moduleTitle=J Viral Hepat：纳尼？！HCV治疗失败也会增加肝癌风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=450c6850e5c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257631, encodeId=d637125e6315d, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Clin infect dis：震惊！美国CDC当前指导方针可能漏检高达四分之一的HCV感染病例, objectType=article, longId=66875, objectId=af64668e514, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af64668e514, replyNumber=0, likeNumber=48, createdTime=2016-04-22, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af64668e514, moduleTitle=Clin infect dis：震惊！美国CDC当前指导方针可能漏检高达四分之一的HCV感染病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af64668e514)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257630, encodeId=6a89125e630a0, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=ILC 2016：Harvoni治疗肾移植的HCV患者仍安全有效, objectType=article, longId=66808, objectId=a992668086e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a992668086e, replyNumber=0, likeNumber=61, createdTime=2016-04-21, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a992668086e, moduleTitle=ILC 2016：Harvoni治疗肾移植的HCV患者仍安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a992668086e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257629, encodeId=c251125e62931, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=2016国际肝病会议：治疗基因型1型和4型HCV感染，Elbasvir/grazoprevir方案的安全性和疗效性更优, objectType=article, longId=66791, objectId=ff0366e9153, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0366e9153, replyNumber=0, likeNumber=63, createdTime=2016-04-21, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0366e9153, moduleTitle=2016国际肝病会议：治疗基因型1型和4型HCV感染，Elbasvir/grazoprevir方案的安全性和疗效性更优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff0366e9153)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257628, encodeId=cef8125e62887, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=ILC 2016：Harvoni对青少年HCV依然高度有效, objectType=article, longId=66615, objectId=688a6661543, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=688a6661543, replyNumber=0, likeNumber=57, createdTime=2016-04-19, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=688a6661543, moduleTitle=ILC 2016：Harvoni对青少年HCV依然高度有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=688a6661543)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257627, encodeId=9213125e627dc, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=ILC 2016：:葡萄牙对所有HCV患者进行普遍治疗1年后，效果显著, objectType=article, longId=66367, objectId=a7c16636ecf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7c16636ecf, replyNumber=0, likeNumber=67, createdTime=2016-04-12, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7c16636ecf, moduleTitle=ILC 2016：:葡萄牙对所有HCV患者进行普遍治疗1年后，效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7c16636ecf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257626, encodeId=4aae125e626bf, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：≥65的HCV感染者，仍可使用LDV/SOF治疗, objectType=article, longId=64424, objectId=bf46644240c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bf46644240c, replyNumber=0, likeNumber=78, createdTime=2016-03-09, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bf46644240c, moduleTitle=Hepatology：≥65的HCV感染者，仍可使用LDV/SOF治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bf46644240c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257625, encodeId=7862125e625dd, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：三种药物联合治疗肝硬化或肝移植的HCV感染者（ALLY-1）, objectType=article, longId=64423, objectId=9b3f644234a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b3f644234a, replyNumber=0, likeNumber=33, createdTime=2016-03-09, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b3f644234a, moduleTitle=Hepatology：三种药物联合治疗肝硬化或肝移植的HCV感染者（ALLY-1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b3f644234a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1257624, encodeId=f6c1125e62458, content=<a href='/topic/show?id=774e856e22' target=_blank style='color:#2F92EE;'>#HCV#</a>, objectTitle=Hepatology：DCV-SOF-RBV治疗HCV基因型3感染的晚期肝脏疾病患者（ALLY-3+）, objectType=article, longId=64417, objectId=ed9d6441e3a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed9d6441e3a, replyNumber=0, likeNumber=54, createdTime=2016-03-09, rootId=0, userName=ymljack, userId=460849, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed9d6441e3a, moduleTitle=Hepatology：DCV-SOF-RBV治疗HCV基因型3感染的晚期肝脏疾病患者（ALLY-3+）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed9d6441e3a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HCV

2020-05-29

ymljack (审核中...)

前往app查看评论内容

#HCV#

Aliment Pharmacol The：真实世界数据告诉你OBV/PTV/r± DSV±RBV治疗HCV的疗效

2016-09-12

ymljack (审核中...)

前往app查看评论内容

#HCV#

丙肝病毒（HCV）研究进展

2016-09-02

ymljack (审核中...)

前往app查看评论内容

#HCV#

治愈HCV感染，我们需要付出多大代价？

2016-08-30

ymljack (审核中...)

前往app查看评论内容

#HCV#

2015INHSU建议——注射吸毒者HCV感染的管理发布

2016-08-17

ymljack (审核中...)

前往app查看评论内容

#HCV#

AIM：接受阿片类药物激动剂治疗的HCV患者使用elbasvir-grazoprevir治疗的SVR12较高

2016-08-11

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：直接抗病毒治疗HCV相关混合冷球蛋白血症是有效和安全的

2016-08-08

ymljack (审核中...)

前往app查看评论内容

#HCV#

Aliment Pharmacol Ther：ARFI成像预测持续HCV病毒应答患者的肝纤维化情况

2016-08-06

ymljack (审核中...)

前往app查看评论内容

#HCV#

AIDS 2016：感染HCV不会增加HIV病毒载量

2016-07-25

ymljack (审核中...)

前往app查看评论内容

#HCV#

“神药”OSU-03012不仅抑制多种肿瘤，也能抑制众多细菌和HIV、HAV、HBV、HCV等众多病毒

2016-07-22

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Natl Cancer Inst：HCV感染可增加头颈癌的发生风险

2016-07-07

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：新方法允许一步法诊断HCV感染

2016-06-11

ymljack (审核中...)

前往app查看评论内容

#HCV#

J Viral Hepat：纳尼？！HCV治疗失败也会增加肝癌风险？

2016-05-19

ymljack (审核中...)

前往app查看评论内容

#HCV#

Clin infect dis：震惊！美国CDC当前指导方针可能漏检高达四分之一的HCV感染病例

2016-04-22

ymljack (审核中...)

前往app查看评论内容

#HCV#

ILC 2016：Harvoni治疗肾移植的HCV患者仍安全有效

2016-04-21

ymljack (审核中...)

前往app查看评论内容

#HCV#

2016国际肝病会议：治疗基因型1型和4型HCV感染，Elbasvir/grazoprevir方案的安全性和疗效性更优

2016-04-21

ymljack (审核中...)

前往app查看评论内容

#HCV#

ILC 2016：Harvoni对青少年HCV依然高度有效

2016-04-19

ymljack (审核中...)

前往app查看评论内容

#HCV#

ILC 2016：:葡萄牙对所有HCV患者进行普遍治疗1年后，效果显著

2016-04-12

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：≥65的HCV感染者，仍可使用LDV/SOF治疗

2016-03-09

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：三种药物联合治疗肝硬化或肝移植的HCV感染者（ALLY-1）

2016-03-09

ymljack (审核中...)

前往app查看评论内容

#HCV#

Hepatology：DCV-SOF-RBV治疗HCV基因型3感染的晚期肝脏疾病患者（ALLY-3+）

2016-03-09

科室
- - 订阅+
  - 更多科室
工具
服务